Oropharyngeal cancer: Current understanding and management

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 17, Issue 2, 2009, Pages 88-94

  Cohan, David M ^a   Popat, Saurin ^a   Kaplan, Seth E ^b   Rigual, Nestor ^a   Loree, Thom ^a   Hicks Jr , Wesley L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Concurrent chemoradiation therapy; Human papilloma virus; Neck dissection; Oropharynx; Squamous cell carcinoma

Indexed keywords

TOLONIUM CHLORIDE;

ALCOHOL ABUSE; AUTOFLUORESCENCE; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; ENDOSCOPY; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN PAPILLOMAVIRUS TYPE 16; IRRADIATION; OROPHARYNX; OROPHARYNX CANCER; OROPHARYNX CARCINOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; UNITED STATES; WESTERN HEMISPHERE;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MANDIBULAR NEOPLASMS; NECK DISSECTION; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; OROPHARYNX; PALATE, SOFT; PAPILLOMAVIRUS INFECTIONS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; TONSILLAR NEOPLASMS;

EID: 67849110386     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32832984c0     Document Type: Review

References (24)

1. Osborne RF, Brown JJ. Carcinoma of the oral pharynx: an analysis of subsite treatment heterogeneity. Surg Oncol Clin N Am 2004; 13:71-80.
2. Lin DT, Cohen SM, Coppit GL, Burkey BB. Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngol Clin North Am 2005; 38:59-74. (Pubitemid 40092928)
3. Douglas WG, Rigual NR, Giese W, et al. Advanced soft palate cancer: the clinical importance of the parapharyngeal space. Otolaryngol Head Neck Surg 2005; 133:66-69. (Pubitemid 40980964)
4. Shah KV, Westra WH. Genital HPVs in the aerodigestive tract: etiologic association with a subset of oropharyngeal/tonsillar cancers and with recurrent respiratory papillomatosis. Dis Markers 2007; 23:235-245.
5. Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 2007; 29:779-792. This study provides a comprehensive review of epidemiological trends in oral cancer.
6. Syrjänen S. Human papillomavirus in head and neck cancer. J Clin Virol 2005; 32:59-66. (Pubitemid 40332590)
7. Kreimer AR, Clifford GM, Boyle P, Francechi S. Human papilloma virus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:467-475. (Pubitemid 40270113)
8. Puscas L. The role of human papilloma virus infection in the etiology of oropharyngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg 2005; 13:212-216. (Pubitemid 41003847)
9. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24 (Suppl 3):1-10. (Pubitemid 44293019)
10. Fakhry K, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006; 24:2606-2611. (Pubitemid 46622080)
11. Li G, Sturgis EM. The role of human papillomavirus in squamous carcinoma of the head and neck. Curr Oncol Rep 2006; 8:130-139.
12. Monk BJ, Tewari KS. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol 2007; 107:6-13.
13. Epstein JB, Gorsky M, Cabay RJ, et al. Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma. Can Fam Physician 2008; 54:870-875. An excellent review of screening techniques with special relevance to the primary care provider.
14. Epstein JB, Sciubba J, Silverman S Jr, Sroussi HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 2007; 29:948-958.
15. Stambuk HE, Karimi S, Lee N, Patel SG. Oral cavity and oropharynx tumors. Radiol Clin North Am 2007; 45:1-20.
16. Scully C, Bagan JV. Recent advances in oral oncology 2007: imaging, treatment and treatment outcomes. Oral Oncol 2008; 44:211-215. A concise review of the most modern topics in oral oncology.
17. Weber AL, Romo L, Hashimi S. Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation. Neuroimaging Clin N Am 2003; 13:443-464. (Pubitemid 37025603)
18. Zima AJ, Wesolowski JR, Ibrahim M, et al. Magnetic resonance imaging of oropharyngeal cancer. Top Magn Reson Imaging 2007; 18:237-242. (Pubitemid 47480727)
19. Moyer JS, Wolf GT, Bradford CR. Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2004; 12:82-87. (Pubitemid 38420194)
20. Foote R, Olsen K, Davis D, et al. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head Neck 1993; 15:300-307. (Pubitemid 23174894)
21. Weber R, Gidley P, Morrison W, et al. Treatment selection for carcinoma of the base of tongue. Am J Surg 1990; 160:415-419. (Pubitemid 20346334)
22. Hicks WL Jr, Kuriakose MA, Loree TR, et al. Surgery versus radiation therapy as single-modality treatment of tonsillar fossa carcinoma: the Roswell Park Cancer Institute experience (1971-1991). Laryngoscope 1998; 108:1014-1019.
23. Rigual NR, Wiseman SM. Neck dissection: current concepts and future directions. Surg Oncol Clin N Am 2004; 13:151-166. (Pubitemid 38328499)
24. Genden EM, Rinaldo A, Jacobson A, et al. Management of mandibular invasion: when is a marginal mandibulectomy appropriate? Oral Oncol 2005; 41:776-782.